Cabaletta Bio Announces FDA Granted Orphan Drug Designation to CABA-201 for Treatment of Myositis

February 1, 2024 by Gias ul Hassan

PHILADELPHIA, Feb. 01, 2024 (GLOBE NEWSWIRE) — Cabaletta Bio, Inc. (Nasdaq: CABA), a clinical-stage biotechnology company focused on developing and launching the first curative targeted cell therapies for patients with autoimmune diseases, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to CABA-201, a 4-1BB-containing fully human CD19-CAR … Read more

BioSenic patent granted in Canada for broader protection of ATO therapeutic platform

January 30, 2024 by Gias ul Hassan

PRESS RELEASE – INSIDE INFORMATION BioSenic patent granted in Canada for broader protection of its ATO therapeutic platform Composition-of-matter patent covers the therapeutic use of arsenic salts and metal ions through various routes of administration. Enriched IP portfolio protects arsenic trioxide (ATO) use combined with copper ions delivery, which has demonstrated increased therapeutic potential … Read more

Sequana Medical granted US CPT® III reimbursement codes for alfapump® system

January 3, 2024 by Gias ul Hassan

PRESS RELEASE Strengthens US reimbursement position Builds upon PMA application submitted to the US FDA on 27 December 2023 Ghent, Belgium – 03 January 2024 – Sequana Medical NV (Euronext Brussels: SEQUA) (the “Company” or “Sequana Medical“), a pioneer in the treatment of fluid overload in liver disease, heart failure and cancer, today announces that … Read more

Indian superstar Rajinikanth’s wife granted bail in fraudulent case involving actor’s 2014 film, ‘Kochadaiiyaan’

December 28, 2023 by Gias ul Hassan

KUALA LUMPUR, Dec 28 — A Magistrate’s Court in Bangalore granted conditional bail to Tamil film actor Rajinikanth’s wife, Latha Rajinikanth, on Tuesday in a fraud case involving the actor’s 2014 film, Kochadaiiyaan. The court granted bail on a personal bond of Rs1 lakh (RM5,544) and cash surety of Rs25,000 (RM1,386). Kochadaiiyaan, a 3D animated … Read more

May 17, 2024